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Results   
Screening cultures for TMAO reductase activity. The presence of TMAO in 
media increased the growth rate of Enterobacteriaceae; while it did not affect 
the growth rate of lactic acid bacteria, TMAO increased the biomass of these 
bacteria (Fig. 2). 
 
 
 
 
 
Enterobacteriaceae produced the greatest amount of TMA from TMAO (38.79 
± 11.08 mM [14.92–53.91 mM]; n=20). Members of other families of bacteria 
produced low levels of TMA from TMAO (0.02–4.52 mM). Caecal/small-
intestinal isolates of Escherichia coli produced more TMA from TMAO than 
their faecal counterparts (Fig. 3). Lactic acid bacteria (LAB) did not convert 
TMAO to TMA, but their production of lactate was greatly increased when 
they were grown in the presence of TMAO (Fig. 4). 
 
 
 
 
 
 
 
 
 
 
Effect of TMAO on gut bacteria within a mixed system. Abundance of 
Enterobacteriaceae (probe Ent) significantly increased in the presence of 
TMAO (Fig. 5). Huge variability was seen in the amounts of TMA and DMA 
produced, though levels of both steadily increased throughout the 9 h 
fermentation. No significant differences were seen between the lactate and 
acetate levels of TMAO and control systems (possibly due to cross-feeding). 
 
 
 
 
 
 
Conclusion 
Enterobacteriaceae made the greatest contribution to the conversion of 
TMAO to TMA, both in pure culture and in a mixed microbiota. This work 
clearly demonstrates different metabolic activity of strains of the same 
bacterial species from different gut niches. 
 
 
 
 
 
Introduction  
Dietary sources of methylamines such as choline, trimethylamine (TMA), 
trimethylamine N-oxide (TMAO), phosphatidylcholine (PC) and carnitine 
are present in a number of foodstuffs, including meat, fish, nuts and eggs. 
It is recognized that the gut microbiota is able to convert choline to TMA in 
a fermentation-like process (Fig. 1).1 Similarly, PC and carnitine are 
converted to TMA by the gut microbiota. It has been suggested that TMAO 
is subject to ‘metabolic retroversion’ in the gut (i.e. it is reduced to TMA 
by the gut microbiota, with this TMA being oxidized to produce TMAO in 
the liver).2 However, to date the role of the gut microbiota in TMAO 
degradation has not been investigated. 
 
 
 
 
 
 
 
 
Methods 
Screening of bacteria for ability to reduce TMAO. Sixty-six strains of 
human faecal and caecal bacteria (Table 1) were screened anaerobically 
for their ability to utilize TMAO using liquid minimal media with and without 
1% (w/v) TMAO. Metabolites in spent media were profiled by Proton 
Nuclear Magnetic Resonance (1H NMR) spectroscopy.3 
In vitro fermentation systems. Anaerobic, stirred, pH-controlled, batch 
culture fermentation systems were performed using minimal broth with and 
without 1% (w/v) TMAO and inoculated with faecal homogenates prepared 
from freshly voided stool samples (three healthy humans; one male, two 
females; age range 20–31 y). Samples were taken at 0, 1, 2, 3, 4, 5, 6 and 
9 h for microbiological (fluorescence in situ hybridization; FISH) and 
metabolite (1H NMR) profiling. 
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Fig. 2. Representative growth curves for strains 
grown with (red) or without (blue) TMAO. (a) 
Escherichia coli D1(2); (b) Citrobacter gillenii L26-
FAA1; (c) Klebsiella pneumoniae L26-FAA1; (d) 
Enterococcus gallinarum D6(5); (e) Streptococcus 
anginosus D5(12); (f) Clostridium perfringens L20-
BSM1. Data are shown as mean ± SD (n = 3).  
Fig. 5. Screening strains for lipolytic  and lipase activity. E. coli and S. aureus were used as negative 
and positive controls, respectively, in both tests. Zones of clearing around inocula on tributyrin agar 
indicate lipolytic activity (left panel); zones of fluorescence around or under inocula on olive oil/
rhodamine B agar indicate lipase activity (right panel). 
Fig. 1. Proposed methylamines’ pathway, 
an example of the microbial–mammalian co-
metabolic axis. TMA is derived from 
microbial degradation of dietary 
methylamines such as TMAO, choline, PC 
and carnitine in the intestinal lumen. TMA is 
absorbed by the host to be N-oxidized into 
TMAO by hepatic flavin mono-oxygenases 
(FMO) and demethylated into 
dimethylamine (DMA) and 
monomethylamine (MMA) by cytochrome 
P450s (CYP) in the liver during first-pass 
metabolism. TMAO, and a trace amount of 
unconverted TMA, can be readily detected 
in human blood and urine by NMR. DAG, 
diacylglycerols; FA, fatty acids; MAG, 
monoacylglycerols.  
Fig. 3. Caecal Escherichia coli produce more TMA 
from TMAO than faecal isolates. Significant adjusted P 
values (Benjamini–Hochberg4) shown above bars in 
the graph indicate the caecal isolates were 
significantly different from faecal isolates for a 
particular metabolite. 
Table 1. Gut bacteria screened for their ability to utilize TMAO 
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Genus Species included No. of 
strains 
Source 
Actinomyces odontolyticus, viscosus 2 Caecum 
Bacteroides fragilis, vulgatus 3 Caecum/faeces 
Bifidobacterium adolescentis, animalis subsp. lactis, bifidum, breve, dentium, 
gallicum, longum, longum subsp. infantis, longum subsp. longum, 
pseudocatenulatum, unknown 
17 Caecum/faeces/
intestine 
Citrobacer gillenii, koseri 2 Caecum 
Clostridium bifermentans, innocuum, ramosum, paraputrificum, perfringens, 
sporogenes 
6 Caecum/faeces 
Enterococcus faecalis, faecium, gallinarum 5 Faeces 
Escherichia coli 16 Caecum/faeces 
Fusobacterium ulcerans 1 Caecum 
Hafnia paralvei 1 Caecum 
Klebsiella pneumoniae subsp. pneumoniae 1 Caecum 
Lactobacillus fermentum, rhamnosus 2 Caecum 
Parabacteroides johnsonii 1 Caecum 
Pseudomonas aeruginosa 1 Caecum 
Staphylococcus hominis 1 Faeces 
Streptococcus anginosus, gallolyticus, oralis, sanguinis, unknown, vestibularis 7 Caecum/faeces 
Fig. 4. Increased lactic acid production by LAB in 
the presence of TMAO. Enterobacteriaceae, n = 
20; Bifidobacteriaceae, n = 17; Streptococcaceae, 
n = 7; Enterococcaceae, n = 5. *, Significantly 
different from its negative control (adjusted P 
values shown). 
Fig 5. (L) Growth of 
Enterobacteriaceae (Ent) is 
promoted in the presence of 
TMAO. Red lines, TMAO-
containing systems; blue lines, 
negative controls. Data are shown 
as mean ± SD (n = 3). *, 
Significantly different (P < 0.05) 
from the control at the same time 
point. (R) Bidirectional clustering of 
correlation matrix of FISH data and 
data for the six metabolites found 
in highest amounts in the NMR 
spectra from the batch-culture 
samples. +, Significant (P < 0.05).  
